文献速递食管胃疾病与幽门螺杆菌消化道肿瘤与早癌

循环性激素与胃癌和结直肠癌相关,但与食管腺癌无关:英国生物银行研究

Circulating Sex Hormones Are Associated With Gastric and Colorectal Cancers but Not Esophageal Adenocarcinoma in the UK Biobank.
PubMed 文献 · Am J Gastroenterol · 2021-01-01

该研究基于英国生物银行219425名男性和147180名女性,采用化学发光免疫分析法测定性激素,通过Cox回归分析性激素与食管癌、胃癌、结直肠癌风险的前瞻性关联。中位随访10年共识别376例食管腺癌、108例食管鳞癌、333例胃癌和2868例结直肠癌。男性SHBG升高与胃癌风险增加相关(Q4 vs Q1 HR 1.43,95%CI 0.95-2.17,Ptrend=0.01),但与结直肠癌风险降低相关;女性游离睾酮升高与食管鳞癌和结直肠癌风险降低相关;未发现与食管腺癌的关联。

要点

  • 男性SHBG最高四分位与胃癌风险增加相关,趋势P=0.01。
  • 男性SHBG与结直肠癌风险降低相关,趋势P=0.04。
  • 女性游离睾酮与食管鳞癌和结直肠癌风险降低相关。

核心结论

  • 男性SHBG较高与胃癌风险增加但结直肠癌风险降低相关,女性游离睾酮较高与食管鳞癌和结直肠癌风险降低相关,未发现性激素与食管腺癌的关联。

研究设计与样本

  • 前瞻性队列研究,纳入英国生物银行219425名男性和147180名女性,使用化学发光免疫分析法测定性激素,通过Cox比例风险回归分析。

主要发现

  • 随访10年期间识别376例食管腺癌、108例食管鳞癌、333例胃癌和2868例结直肠癌。
  • 男性SHBG与胃癌风险:Q4 vs Q1 HR 1.43(95%CI 0.95-2.17),Ptrend=0.01。
  • 女性游离睾酮与食管鳞癌风险:Q4 vs Q1 HR 0.32(95%CI 0.11-0.98),Ptrend=0.05。
  • 男性SHBG与结直肠癌风险:Q4 vs Q1 HR 0.89(95%CI 0.77-1.03),Ptrend=0.04。
  • 女性游离睾酮与结直肠癌风险:Q4 vs Q1 HR 0.80(95%CI 0.66-0.97),Ptrend=0.01。

临床怎么用

  • 性激素水平可能作为胃肠道肿瘤风险分层的参考,但需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Gastrointestinal cancers show an unexplained male predominance, but few prospective studies have investigated sex hormones and gastrointestinal cancer risk. This study aimed to determine the impact of circulating sex hormones on risk of esophageal, gastric, and colorectal cancers in men and women. METHODS: We included 219,425 men and 147,180 women from the UK Biobank. Sex hormones were quantified using chemiluminescent immunoassay. Gastrointestinal cancers were identified from cancer registry linkages. Sex hormone concentrations and risk of gastrointestinal cancers were investigated using Cox proportional hazards regression. RESULTS: During the 10 years of follow-up, 376 esophageal adenocarcinoma, 108 esophageal squamous cell carcinoma, and 333 gastric and 2,868 colorectal cancer cases were identified. Increased hazard ratios (HRs) were found for sex hormone-binding globulin (SHBG) and risk of gastric cancer in men (Q4 vs Q1 HR 1.43, 95% confidence interval [CI] 0.95-2.17, Ptrend = 0.01). Free testosterone was inversely associated with esophageal squamous cell carcinoma in women (Q4 vs Q1 HR 0.32, 95% CI 0.11-0.98, Ptrend = 0.05). For colorectal cancer, SHBG was associated with a reduced risk among men (Q4 vs Q1 HR 0.89, 95% CI 0.77-1.03, Ptrend = 0.04) and free testosterone concentrations was associated with a reduction in risk among women (Q4 vs Q1 HR 0.80, 95% CI 0.66-0.97, Ptrend = 0.01). No associations were found for esophageal adenocarcinoma. DISCUSSION: In this large prospective investigation of prediagnostic sex hormones and risk of gastrointestinal cancers, men with higher SHBG concentrations had higher gastric, yet lower colorectal, cancer risks, whereas women with higher free testosterone levels had a lower risk of esophageal squamous cell carcinoma and colorectal cancer.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. McMenamin ÚC, Liu P, Kunzmann AT, et al. Circulating Sex Hormones Are Associated With Gastric and Colorectal Cancers but Not Esophageal Adenocarcinoma in the UK Biobank. Am J Gastroenterol. 2021. PMID: 33156012. doi:10.14309/ajg.0000000000001045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。